Abstract
Background and aim Ovarian cysts, fluid-filled sacs, are common, benign, and typically go away on their own. Ovarian cysts can be diverse, including theca-lutein, follicular, polycystic, peritoneal inclusion, and hemorrhagic cysts. Therefore, this study aims to investigate the role of sclerotherapy in the treatment of recurrent or persisting non-neoplastic ovarian cysts. Patients and methods A cohort study enrolled 52 patients who presented with non-neoplastic ovarian cysts based on ultrasound findings and Tumor markers analysis, underwent sclerotherapy (injection of 1 ampule of Polidocanol 20 ml amount (AMOUN)), to detect its effect in the rate of cyst recurrence, all patients were followed-up with ultrasound and Color Doppler sonography at 1, 3, and 6 months after the procedure. In some cases of cyst persistence, a second aspiration and re-injection with Polidocanol were attempted (n=9), while the rest refused repeated aspiration and needed medical management or surgery. The main outcome measure was the disappearance of the cyst and the avoidance of surgery. The cyst was considered resolved if follow‑up revealed either no cystic lesion or only a follicle‑like cyst no more than 30 mm in diameter. This study was conducted at Al-Azhar University Hospital, Assiut, from September 2022 to January 2024. Results As regards the total recurrence of studied cases, there were 35 (67.3%) cases with resolved cysts and 17 (32.7%) cases with recurrent or persistent cysts. High statistically significant relation between recurrence and cyst size (P<0.001). It was found that the larger the cyst, the greater the recurrence rate. Conclusion Sclerotherapy emerges as an effective therapeutic option for the management of non-neoplastic ovarian cysts.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call